Answers are grounded in this paper and cite their sources.
A dog model for chemotherapy and radiation-induced testicular damage was created to study the protective potential of superactive analogue of luteinizing hormone-releasing hormone, buserelin. Buserelin appeared to offer protection of the canine germinal epithelium against cyclophosphamide, cisplatinum and radiation. Clinical trials with buserelin in patients of reproductive age undergoing treatment for cancer should be encouraged.
No takes yet. Share an insight, caveat, or question.
Nseyo et al. (1985) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: